We investigated the evidence of gastric protection for ulcer and gastritis by Cinnamomi Ramulus (Cinnamomum cassia Blume, Geiji, CR) extract and its several constituents. CR ethanolic extract showed the potent antioxidant activity and cytotoxicity of Helicobacter pylori (H. pylori) and acid-neutralizing capacity. Especially, eugenol exerted a signiˆcant antioxidant activity and inhibited the colonization of H. pylori. In vivo test, eugenol and cinnamic acid signiˆcantly inhibited HCl/ethanol-induced gastric lesions and increased the mucus content though they didn't inhibit gastric secretion eŠectively. Taken together, eugenol and cinnamic acid, which were isolated from CR, exhibited the antioxidant activity in vitro and protective eŠect against gastric damage in vivo through stimulation of mucus secretion and so on. It suggested that they are useful as the neutraceuticals for gastritis.
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INTRODUCTION
Traditional medicine has been extensively used to prevent and cure the human diseases in oriental area. Due to their low toxicity and the side-eŠect free therapeutical performance, the traditional medicine has been attracted considerable attention as alternative drugs recently. In addition, the pharmaceutical researches for active ingredients of medicinal herbs have become important for development of novel medicines.
Cinnamomi Ramulus (Cinnamomum cassia Blume, Geiji, CR) is a well-known traditional medicine for a long time in Korea. The medicinal prescription containing CR on anti-atherosclerosis activity has been used for the treatment of cardiovascular disorders. As a matter of fact, CR is very eŠective in treating thrombosis in those patients who have di‹culties with more conventional antithrombotic drugs. In addition, CR has been used as a remedy for menstrual problems, gastrointestinal disorders, headache, amenorrhea, and postpartum hemorrhage. 1) It was reported that CR has a remarkable central stimulant eŠect, a transient hypertensive eŠect, and positive inotropic and chronotropic eŠects. 1) It has also been known that CR protects the myocardium against ischemia-induced derangement. The inhibitory eŠect of CR on the growth of cancer cell lines such as HepG2 cell and Hep3B cell has been demonstrated for a potential cancer chemopreventive agent in humans, especially in hepatological cancers. 2) In vivo, the feeding CR-extract reduced endothelial damage and the severity of atherosclerosis in cholesterol-fed NZW rabbits. Low density lipoproteins (LDLs) from CR-treated animals contained more vitamin E and were more resistant to oxidation ex vivo. 3) CR inhibits the aggregation of human platelets in a dosedependent manner, and that CR exerts its vasodilator eŠects via an endothelial nitric oxide (NO)-dependent mechanism. CR protects the myocardium against ischemia-induced derangement. An ethanolic extracts of CR contains phenolic compounds that are eŠective in protecting liver microsomes, hepatocytes, and erythrocytes against oxidative damage. CR acts as an antioxidant and antimutagen and to stimulate phase II drug-metabolizing enzymes; it mediates antiin‰ammatory eŠects and inhibits cyclooxygenase and hydroperoxidase functions; and it induces human promyelocytic leukemia cell diŠerentiation.
Cinnamaldehyde, coumarin, b-sitosterol, and protocatechuic acid were isolated from ethanolic extract of CR. 4) Cinnamaldehyde exerts the anti-spasms, analgesic, removal of fever, antimicrobial, anti-cancer, and strength of stomach, and coumarin has biological functions for the anti-aggregation, vascular dilation, antimicrobial, and anti-in‰ammation. 5) Gastric diseases including gastric ulcer, infection of H. pylori, gastritis, and gastric cancer aŠected a large portion of the world population and are induced by several factors, such as stress, smoking, nutritional deˆciencies, and ingestion of nonsteroidal anti-in‰ammatory drugs. 6) Peptic ulcers appear to result from overproduction of gastric acid and or decrease on gastric mucosal protective mechanisms. Consequently, reduction of gastric acid production as well as reinforcement of gastric mucosal protection has been main approaches for peptic ulcer therapy. The recurring gastritis and gastric ulcers are caused by an imbalance between aggressive factors (i.e., gastric acid, pepsin, stimulation of the vagus nerves, secretion of gastrin, and increasing the number of parietal cells) and protective factors (i.e., bicarbonate ion, mucus productivity, mucus secretion, and prostaglandins). 7) Physiological factors of these gastric diseases include acid-pepsin secretion, parietal cell activity, mucosal barrier, mucus secretion, blood ‰ow, cell regeneration, and the release of endogenous protective agents, especially prostaglandins and epidermal growth factors. 8) One of the greatest concerns is to ascertain whether H. pylori-induced gastritis may lead to gastric cancer. According to several epidemiologic studies concerning the association between gastric cancer and H. pylori, the antibodies for H. pylori was increased and higher in the patients with gastric cancer than in the control group. 9) Numerous approaches for the treatment of gastric ulcers have been focused on the control of acid secretion, H. pylori level, and H ＋ /K ＋ -ATPase activity for the alleviation of mucosal damage and in‰ammation. 10) The present work was carried out to investigate the evidence of gastric protection for ulcer and gastritis by CR extract and its several constituents. We expect that CR may be a good candidate for the development of new drugs or neutraceuticals which can be used for the treatment or prevention of gastritis.
MATERIALS AND METHODS

Materials
The young branches of CR were harvested at Kangwon Animals Male Sprague-Dawley rats, weighing 170 210 g, were purchased from Samyook Animal Laboratories, Kyunggi-do, Korea, and were acclimatized to standard laboratory conditions (24±2°C, 55 ±5％ humidity and 12 h light/dark cycle) for 14 days in animal facility in Duksung Women's University. The samples dissolved in saline were administered in a volume of 0.5 ml per 100 g body weight. Saline was given to the control group. The experimental procedures for rats were conducted in accordance with the Guidelines of the Care and Use of Laboratory Animals, Duksung Women's University. The animals were allowed free access to food (standard pellet diet) and water ad libitum. All this study was carried In Vitro Assay Antioxidant activity, acid-neutralizing capacity and anti-H. pylori activity of CR 70 ％ ethanol extract and its constituents were monitored according to the previously study. 11) Brie‰y, antioxidant activity was determined by the scavenging of DPPH free radical, NO-radical 12) and superoxide anion radical. 13) The growth inhibition of H. pylori was investigated by colony counts. Ampicillin was used as a positive control. Acid-neutralizing capacity was determined by titrating with 0.1 N NaOH using methyl orange as an indicator. Hydrotalcite was used as a positive control.
In Vivo Assay The rats administered with eugenol and cinnamic acid were examined by HCl/ ethanol-induced gastric lesion, 14) gastric secretion 7) and mucus secretion 15) according to the previously study 11) . Cimetidine was used as a positive control drug. In mucus secretion assay, sucralfate was used as a positive control. Mucus contents were expressed as microgram of alcian blue determined by standard plots.
RESULTS AND DISCUSSION
In Vitro Study Antioxidant Activity of CR Extract To investigate the scavenging free radicals by CR ethanolic extract and its constituents, the dose-response relationship was studied ( Table 1) . CR ethanolic extract and its constituents had the hydrogen-donating activity to DPPH radicals in concentration-dependent manner. IC 50 value of the reference antioxidant ascorbic acid was found experimentally to be＜1 mg/ml. CR ethanolic extract and eugenol showed a signiˆcant free radical scavenging activity with IC 50 ＜9 mg/ml. However, cinnamaldehyde, cinnamic acid, and coumarin had low antioxidant activity with an IC 50 ＞300 mg/ ml, respectively. The quenching activity for nitric oxide radicals was consistent to DPPH radical scavenging activity results. IC 50 value of CR ethanolic extract for NO radicals was investigated to be 52.88 mg/ ml, and eugenol exerted a potent NO radical quenching action with IC 50 9 mg/ml. In addition, coumarin showed IC 50 ＝27.25 mg/ml of NO radical scavenging. Otherwise, the superoxide radical scavenging activity of CR ethanolic extract and its constituents was weak as compared with DPPH and NO radical scavenging.
Gastric cell and the stomach-tissue injury in acute and chronic in‰ammation are due to the toxicity of reactive oxygen species (ROS) generated in stomach. 16 ) It has been known that several kinds of free radicals are generated in the peptic ulcer and gastritis, but its mechanism is unclear. ROS play an important role in the progress of the injury in the digestive system, 17) and are involved in the pathogenesis of ischemic injury of gastrointestinal mucosa and in other models of mucosal damage induced by nonsteroidal anti-in‰ammatory drugs, ethanol, and H. pylori. 18) The intake of ascorbic acid reduces the gastric cancer risk in a dose-dependent way, and levels of the ascorbic acid are lower than in the normal population in H. pylori-infected patients. The retardation of ascorbic acid for gastric cancer risk might be due to antioxidative function quenching harmful ROS in stomach. ROS also promote mucosal damage by causing degradation of the epithelial basement membrane components, complete alteration of the cell metabolism, and DNA damage. Taken together, it is speculated that CR extract and its constituents had the protective eŠects as a radical scavenger.
Anti-H. pylori Activity of CR Extract Helicobacter pylori is the major microorganism for bacterial gastrointestinal infections, peptic ulcer, and gastric cancer. The acute or chronic in‰ammation and the denaturation of epithelial cells at mucous membrane cause the loss of gastric mucus and gastric cell death in H. pylori-infected patients. The in‰amma-tion and toxic substances by H. pylori cause the damage of gastric epithelial cells. CR ethanolic extract and its constituents were used to run for in vitro experiments on anti-bacterial activity against H. pylori. CR ethanol-extract completely inhibited the colonization of H. pylori at 100 mg/ml concentration, and this eŠect was equivalent to that of ampicillin (10 mg/ml), as shown in Table 2 . Among CR constituents, coumarin, eugenol, and cinnamaldehyde had relatively a potent anti-H. pylori activity.
Antibiotic therapy through the combination of several drugs has been widely used to eradicate H. pylori infections. However, the drug-resistant bacteria need the novel anti-bacterial drugs, and the plants seem to be the ideal sources of novel antibacterial compounds. It is worthy of notice that CR ethanolextract and its constituents killed the H. pylori cells in vitro (＜100 mg/ml) ( Table 2) . Although the relatively high concentration of CR ethanol-extract and its constituents was needed for the suppression of H. pylori growth, the CR ethanol-extract and its constituents are considered to be more eŠective in use, because the CR extract has extra protective functions for stomach as well as antibacterial eŠect. The acute gastritis by H. pylori-infection is associated with the development of hypochlorhydria, which is a pheno- menon suspected to be caused by an infectious agent.
Additionally, H. pylori-infection increases the free radical production in the in‰ammatory region of stomach. A delicate balance between the free radicals and antioxidants like superoxide dismutase (SOD) and ascorbic acid is the important for physiological functions of the gastric cells. In the deˆcient antioxidant defenses, the abundantly produced free radicals can initiate lipid peroxidation and DNA damage, which leads to the cellular destruction, chromosomal aberration, andˆnally cancer. In fact, H. pylori were found in 70 90％ of patients with gastric adenocarcinoma. 19) Furthermore, the epidemiologic features of gastric adenocarcinoma and H. pylori-infection are similar, so that H. pylori-infection now is believed to be a risk factor for gastric adenocarcinoma. 20) Therefore, in patients with mucosal H. pylori-infection, the eradication of this microorganism is necessary to cure both infection and ulcer disease. 21) Taken together, the anti-bacterial activity of CR extract may suppress several H. pylori-caused patho-physiological responses, such as the decrease of ascorbic acid secretion, gastric ulcer, the decrease of resistance for gastric carcinogens, and the induction of mucosal hyperproliferation.
Acid-neutralizing Capacity (ANC) of CR Extract
The CR ethanol-extract inhibited 11.9％ of NaOHconsumption volume as compared to control, whereas cinnamaldehyde, eugenol and coumarin were the low inhibitory action ( Table 3) . ANC of CR extract is expected to exert the protective in‰uence on stomach damage by secretion of gastric acid, when CR extract is taken in a long period. Generally the antacids are eŠective in accelerating healing of duodenal and gastric ulcers, and the ulcer healing action by antacids is due to the neutralization of gastric luminal acid. 22) In present study, the ANC of CR extract and its constituents imply the increase of pH in gastric content in vitro. This result suggests that the CR extract may contribute for gastric protection, and the acidneutralizing activity works in a variety of conditions, such as the stomach upset, heartburn, the non-ulcer dyspepsia, and the veriˆed gastric and duodenal ulcers. Although CR ethanol-extract and its constituents had less acid-neutralizing capacity than hydrotalcite, it is expected it might be helped for the stomach protection as nutraceuticals.
In Vivo Study
EŠects of Eugenol and Cinnamic Acid on HCl/ Ethanol-induced Gastric Lesions
The HCl/ethanol-induced gastric mucosal damage is associated with the overproduction of free radicals, which lead to an increase of lipid peroxidation. 23) Ethanol induces both wide ulcers and petechial lesions within a relatively short time, which makes this technique suitable for screening methods for investigation of antiulcer drugs. 24) The mechanism of ethanol-induced gastric lesions varies in the depletion of gastric mucus content, damaged mucosal blood ‰ow, and mucosal cell injury. This action may be related to an antacid eŠects or cytoprotective properties for the gastric mucosa in ethanol-induced gastric lesion in mice. Also, it is suggested to be due to the activation of cellular protection, the reduction of mucosal prostaglandins, and the reduction of gastric vascular permeability. 25) The eŠects of eugenol and cinnamic acid on the HCl/ethanol-induced lesion were investigated in this study. Intragastric administration of HCl/ethanol (60％ in 150 mM HCl) made gastric tissues thinner and fainter, and multiple band-like lesions in the gastric mucosa, being 87.0±13.51 mm of the lesion index ( Table 4) , whereas any gastric lesions were not observed in the normal mice (data not shown).
The oral administration of eugenol and cinnamic acid diminished HCl-induced gastric lesions in mice at signiˆcant diŠerence. And it is anticipated that this action might be due to the inhibition on cytotoxicity of HCl as attack factor or the stimulation of gastric mucus as defense factor. The severity of these lesions was dose-dependently reduced by p.o. administration of eugenol and cinnamic acid. Especially eugenol (100 mg/kg) inhibited approximately 65.8％ of HCl/ ethanol-induced gastric lesions, and was superior to cimetidine (200 mg/kg), a positive control (approximately 47.5％ inhibition). Additionally the pretreatment of mice with cinnamic acid reduced approximately 11.5 and 42.8％ of gastric lesions at 50 and 100 mg/kg dose, respectively.
From this result, eugenol and cinnamic acid showed anti-ulcer activity, and especially against HCl /ethanol induced ulcers in rats dose-dependently. Therefore this result implies that CR has eŠective anti-ulcer activity against HCl / ethanol-induced stomach lesions.
EŠects of Eugenol and Cinnamic Acid on Gastric Secretion
We measured the gastric-juice parameters, such as gastric volume and pH, after submitting the rats to pylorus ligature with or without the eugenol and cinnamic acid intraduodenally. Doses of eugenol and cinnamic acid were selected based on suppression of HCl-ethanol-induced gastric lesion ( Table 4 ). The eŠects of eugenol and cinnamic acid on gastric secretion, pH, and acid output in pylorusligated rats were showen in Table 5 . The amount of gastric secretion by eugenol was approximately 3.6 ml, which were less than that of control (4.2 ml), whereas the amount of gastric secretion by cinnamic acid was approximately 5.2 ml. Eugenol and cinnamic acid increased the hydrogen ion concentration to 1.2 and 1.0 in gastric juice, respectively, as compared to control (pH 1.38). Eugenol showed the decline of total acid output to 0.37 mEq/4 h, as compare to control (0.38 mEq/4 h) without signiˆcantly diŠerence.
Taken together, though eugenol and cinnamic acid did not inhibit eŠectively gastric secretion, it was expected to suppress the attack factor through the reduction of gastric secretion, and to play important role to anti-gastric eŠect, including the reduction of lesion index in vivo.
EŠects of Eugenol and Cinnamic Acid on Mucus Secretion Induced Absolute Ethanol
In the mucus secretion model, even though ethanol induces to reduce the amount of mucus secretion in the rats, eugenol and cinnamic acid enhanced the mucus secretion. Eugenol and cinnamic acid (100 mg/kg) signiˆcantly increased the mucus content to approximately 183.5 and 213.4 mg, respectively, which was superior to that of control (173.9 mg) by the induction of absolute ethanol ( Table 6 ). Eugenol and cinnamic acid might protect stomach from the attackfactor by increase of mucus secretion, as well as by the suppression of HCl/ethanol-induced gastric lesions. The amount of mucus secretion by sucralfate, an eŠective medicine for anti-ulcer, was lower than that of control group. The reason might be expected to be a protective action of sucralfate for stomach damage through sucralfate-coating, not to be the increase of mucus secretion in response to ethanol irritation.
Taken together, CR ethanol-extract showed the antioxidant activity, acid-neutralizing capacities, and the partial inhibition of H. pylori. Eugenol and cinnamic acid, which were isolated from CR, exhibited the potent inhibitory activity against HCl/ethanol-induced gastric lesion and the reduction of gastric secretion. Therefore, CR ethanol-extract, eugenol, and cinnamic acid are expected to have potential protective eŠect against gastritis.
